James A. Bianco
THE LATEST salvo from Congress in the battle over drug prices is legislation introduced by Senator Hillary Clinton and others that would create a legal pathway for approval of "follow-on biologics" -- newer versions of biological products currently on the market. (Full article: 465 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
